Anhui Anke Biotechnology | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
89,870.10
108,771.20
132,431.00
197,872.90
281,782.60
264,751.90
Depreciation, Depletion & Amortization
16,070.60
24,225.10
28,524.50
48,285.50
55,908.00
59,015.80
Other Funds
32,223.40
33,000.00
101,712.70
221,685.50
3,810.40
37,194
Funds from Operations
105,775.20
135,957.60
163,127.10
279,005.10
327,649.30
353,206.20
Changes in Working Capital
47,436.60
21,510.70
41,016.90
13,522.10
44,921.90
62,388.30
Net Operating Cash Flow
58,338.50
114,446.90
122,110.20
292,527.20
282,727.40
290,817.90
Capital Expenditures
31,635.60
88,039.10
36,951.20
69,179.80
131,777.70
Sale of Fixed Assets & Businesses
530.10
22.00
113.20
36,686.30
30,404.50
Purchase/Sale of Investments
-
4,000.00
94,100.00
32,588.80
102,390.00
Net Investing Cash Flow
31,105.60
158,684.50
272,857.20
434,846.10
211,943.20
Cash Dividends Paid - Total
46,116.80
47,724.20
43,553.80
61,179.60
82,140.20
Issuance/Reduction of Debt, Net
-
-
-
44,480.80
-
Net Financing Cash Flow
13,893.40
4,724.20
58,158.80
204,986.80
88,329.80
Net Change in Cash
13,095.70
48,973.50
92,584.30
62,669.60
17,550.10
Free Cash Flow
26,702.90
26,407.80
85,159.00
223,347.40
150,949.60
Deferred Taxes & Investment Tax Credit
1,608.40
1,321.50
1,573.20
1,602.70
5,940.20
7,755.50
Net Assets from Acquisitions
-
66,667.40
141,919.30
369,763.80
8,180.00
Change in Capital Stock
-
10,000.00
-
-
-
Exchange Rate Effect
244.00
11.70
3.80
1.70
4.40
About Anhui Anke Biotechnology
View Profile
